ID   LKA29
AC   CVCL_ZX83
SY   LCL(KA)-derived iPSC, clone #29
DR   GEO; GSM2185122
DR   Wikidata; Q102114465
RX   PubMed=27716287;
RX   PubMed=30127392;
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX85 ! KA(LCL)
SX   Male
AG   40Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 5
//
RX   PubMed=27716287; DOI=10.1186/s13041-016-0267-6; PMCID=PMC5046991;
RA   Fujimori K., Tezuka T., Ishiura H., Mitsui J., Doi K., Yoshimura J.,
RA   Tada H., Matsumoto T., Isoda M., Hashimoto R., Hattori N.,
RA   Takahashi T., Morishita S., Tsuji S., Akamatsu W., Okano H.;
RT   "Modeling neurological diseases with induced pluripotent cells
RT   reprogrammed from immortalized lymphoblastoid cell lines.";
RL   Mol. Brain 9:88.1-88.14(2016).
//
RX   PubMed=30127392; DOI=10.1038/s41591-018-0140-5;
RA   Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R.,
RA   Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., Okano H.;
RT   "Modeling sporadic ALS in iPSC-derived motor neurons identifies a
RT   potential therapeutic agent.";
RL   Nat. Med. 24:1579-1589(2018).
//